Latest filing published 23 Nov 2020 for Arrowhead Pharmaceuticals, INC., €915k.
Filing timeline
BuySaleInsider track record
Curt Bradshaw: trading record in brief
All filings by Curt Bradshaw on record concern Arrowhead Pharmaceuticals, Inc. We count 2 filings; the first trade dates from 19 November 2020 and the latest from 20 November 2020.
On the market, this insider has only sold: 2 sales, €1.8M in total.
The record was last updated on 23 November 2020 with an open-market sale (€915k) in Arrowhead Pharmaceuticals, Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Curt Bradshaw
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,625 shares@ US$69.3950.3% of flowCommon StockSEC:0001209191-20-060047:0
- 15,625 shares@ US$68.7349.7% of flowCommon StockSEC:0001209191-20-060047:1
2 of 2 declarations
